索尼:生命科学新产品:细胞分析仪

索尼:生命科学新产品:细胞分析仪

-从研究到细胞药物制造“CGX10”-

索尼:

执行细胞水平分析,例如开发细胞分析仪,

我们正在为尖端医学研究开发生命科学业务。

细胞分离系统
“CGX10”

1月26日,

秋季,我们将发布封闭式细胞分离系统“CGX10”,它可以高速、高精度地分选新靶向细胞。

细胞免疫疗法:

最近,细胞免疫疗法作为癌症和自身免疫性疾病的新治疗方法受到关注。

“CGX10”对单元格进行排序:

在这种治疗方法所必需的细胞药物的生产中,越来越需要以高精度和高纯度分离细胞。

在细胞药物制造中使用“CGX10”:

传统产品用于大学和制药公司的基础研究。

这个产品:

用于细胞药物制造工艺开发,
医药产品的后续生产控制,
有可能发展成符合质量控制标准的细胞生产。

“CGX10”的特点:

它不同于在开放空间中对细胞进行分类的传统方法。

因为可以在不接触外界空气的封闭空间内进行
在保持无菌的同时
它可以设计成可以分离细胞。
您可以戴着手套操作触摸面板。

“CGX10”的性能:

照射 4 束激光(405nm / 488nm / 561nm / 638nm)。

细胞类型识别:

识别产生的细胞类型
基于 10 个参数(特征)
对大量细胞进行分类。
对于每秒 15,000 件的分析处理速度,

以 97% 的高精度实现细胞分离纯度。

细胞分选原理:

通过适当控制液体,

可以预期通过最大限度地减少细胞损伤来保持高存活率。

这将导致

有助于提高细胞分离后培养过程和细胞药物制造过程的效率。

由于本机耗材为一次性用品,

管路套件可适用于每位患者,防止标本相互污染。

CNET 日本

https://japan.cnet.com/article/35182695/

Sony Introduces New Closed Cell Isolation System CGX10 for use in Production of Advanced Cell Therapy Products

Sony Corporation

today introduced a new Cell Isolation System, CGX10, which sorts cells at high speed and high purity in a closed system.

The CGX10’s design

enables sorting of cells in a manner that is designed to be closed off from the outside environment,

making it possible to analyze and isolate cells while maintaining a sterile state. This is especially important in fields

such as cell-based immunotherapy, which has been gaining recognition as a treatment for cancer and autoimmune disorders.

To produce the cell therapies necessary for this treatment,

there is an increasing demand for isolating cells with high purity and high viability in a sterile manner.

It is also expected that
this product could be utilized in research for developing cell-based products for fields such as cell therapy and regenerative medicine.

It can also contribute
to the development of GMP compliant manufacturing processes for cellular products.

By introducing CGX10,
Sony’s Life Science business

will expand from research applications to the field of cell therapies’ development and manufacturing, further contributing to the advancement of cell therapy.

https://www.sony.net/corporate/information/news/202201/22-002E/